AM CET Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology innovation company, today announced that it will discontinue the Phase 3 UNITY study of efgartigimod ...
The camouflaged unit confirms several design details first showcased on the M Neue Klasse concept first unveiled in June 2026 ...
Auto-generate fully-typed test spies from a class — across Vitest, Bun & node:test, with Angular/NestJS/React/Vue/Svelte recipes. A drop-in replacement for jest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results